Join Us Live In-Person at Best of Precision Oncology Conference 2023

Friday, September 29th, 2023 | 7:00 AM – 3:40 PM ET

Event Type: In-person Only

Time: 7:00 AM – 3:30 PM ET

Venue: BMO IFL

Address: 3550 Pharmacy Ave, Scarborough, ON M1W 3E8, Canada

Directions: Google Maps Link

Best of Precision Oncology Conference 2023

Event Landscape

This in-person international flagship event will profile key foundational topics as well as emerging strategies associated with precision oncology. Attendees will be able to optimize diagnosis, treatment selection, and evidence-based management of patients with cancer using emerging diagnostic technologies to personalize and tailor therapies. The event will offer specific insights on precision oncology advances in key tumor areas including breast cancer, hematology, gastrointestinal cancer, genitourinary cancer, lung cancer, melanoma.

Message From Chair - Dr. Heather McArthur

Learning Objectives

  1. State of the art tools for early detection of disease & monitoring of molecularly targeted therapies
  2. Precision oncology biomarkers to guide therapeutic decision making
  3. Precision therapies and understanding the pathways to guide new therapies

Scientific Agenda

7:00 AM – 8:00 AM

Registration and Breakfast Buffet

8:00 AM – 8:15 AM

Welcome Address by Chairs – Dr. Heather McArthur & Dr. Vishal Navani

8:15 AM – 9:00 AM

Merck Breakfast Symposium: Pathology Under Pressure: The Importance of Multidisciplinary Team Coordination in the Era of Precision Oncology – Dr. Patrice Desmeules

9:00 AM – 9:30 AM

Melanoma Updates – Dr. Marcus Butler

9:30 AM – 9:50 AM

Networking Break & Sponsor Exhibits

9:50 AM – 10:20 AM

GU Updates – Dr. Steven Yip

10:20 AM – 10:50 AM

GI Updates – Dr. Eric Chen

10:50 AM – 11:20 AM

Breast Cancer Updates – Dr. Nancy Nixon 

11:20 AM – 11:50 AM


11:50 AM – 12:35 PM

Pfizer Lunch Symposium: Adding Precision to Precision Oncology – Dr. Rosalyn Juergens

12:35 PM – 1:20 PM

Keynote: Novel Promising Targets Beyond Checkpoint Blockade – Dr. Tak Mak

1:20 PM – 1:50 PM

Lung Cancer Updates – Dr. Natasha Leighl

1:50 PM – 2:10 PM

Networking Break & Sponsor Exhibits

2:10 PM – 2:55 PM

Keynote: Seed and Soil Hypothesis and Key Drivers of Metastasis – Relevant Responses to Therapy – Dr. Jasmine Plummer

2:55 PM – 3:25 PM

Lymphoma – Dr. Anca Prica

3:25 PM – 3:30 PM

Closing Remarks by Chairs – Dr. Heather McArthur & Dr. Vishal Navani

Meet the Best of Precision Oncology Conference Co-Chairs

Dr. Heather McArthur

Conference Co-Chair

Heather McArthur, MD, MPH is the Clinical Director of Breast Cancer and Komen Distinguished Chair in Clinical Breast Research at University of Texas Southwestern (UTSW) Medical Center. Dr. McArthur is a medical oncologist with a clinical practice dedicated to the care of patients with breast cancer. Her research activities are focused on innovations in the diagnosis and treatment of breast cancer, with a particular interest in novel immune therapy strategies. For example, she is currently evaluating the impact of tumor destruction with freezing (cryoablation) or radiation in combination with immune stimulation for the treatment of women with early stage breast cancer. It is hoped that by augmenting one’s immune response to the unique biologic features of one’s tumor, that an affected individual may develop long-term immunity against their tumor, and thus, be cured.

Dr. McArthur completed formal medical oncology training in Canada where she was awarded a highly competitive grant that funded an advanced fellowship at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. Thereafter, she joined MSKCC as faculty where she developed the institutional breast cancer immunotherapy program before joining Cedars-Sinai Medical Center in Los Angeles in 2016 and UTSW in Dallas in 2021. She has a Master’s in Public Health with a focus on clinical trial design from Harvard University and has mentored many medical students, residents, fellows, and junior faculty in the conduct and reporting of several studies – two of which directly informed National Comprehensive Cancer Network treatment guidelines.

Dr. McArthur has held several leadership positions in the field including Co-Chair of a Breast International Group Immunotherapy Taskforce, member of a National Cancer Institute (NCI) Breast Cancer Immuno-Oncology (IO) Task Force, Society for Immunotherapy of Cancer (SITC) breast expert panel, and member of an Alliance for Clinical Trials in Oncology IO Committee. She has served the American Society of Clinical Oncology (ASCO) on the Annual Meeting IO Scientific Committee Leader, as co-chair of the Practice Health Committee,  as member of the YIA/CDA Grant Selection Committee, as faculty at the Annual Meeting Grant Writing Workshop, as member of a Guideline Expert Panel, and member of Educational Book Reviewt Panels. She has participated in the ASCO Leadership Development Program; reviewed manuscripts for various high impact journals; authored numerous articles; and served on many study steering committees. She has designed, conducted, and reported on many studies in breast cancer and is currently the co-PI for a large, randomized, international phase 3 study exploring adjuvant chemotherapy with or without immune therapy for the treatment of triple negative breast cancer (IMpassion030).

Dr. Vishal Navani

Conference Co-Chair

Dr. Navani is a staff medical oncologist at the Tom Baker Cancer Centre and Assistant Professor in the Cumming School of Medicine at the University of Calgary. He previously graduated from Oxford and Imperial College London. He holds both Membership of the Royal College of Physicians of the United Kingdom and Fellowship of the Royal Australasian College of Physicians. His academic focus includes the interrogation of large real world datasets spanning tumour streams in order to generate practical insights that can be used in the clinic. He is a clinical director at Glans Look, Canada’s largest lung cancer database. His award-winning real-world research has been published extensively in high impact journals. He plays a lead role in academic endeavours at the University of Calgary such as the Precision Oncology and Experimental Therapeutics programme and has contributed as a clinical expert to CADTH national drug reimbursement decisions. He provides clinical development advice to a number of life science companies. 

Join Us Live In Person Toronto

Registration for Healthcare professionals can be completed above. Industry representatives (both sponsor and non-sponsor) must contact Kelly Allan at [email protected] for registration and sponsorship opportunities. Industry registrations will be not be accepted through the website.


​For sponsorship-related inquiries, please contact Bernadette Gregoris at [email protected].

Best of Precision Oncology Conference 2023 Sponsors









All sales are final, refunds will not be accepted.

Register Now